6533b82afe1ef96bd128c06c
RESEARCH PRODUCT
TCT-350 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First 400 Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry
Bryan P. YanMichael LeeJan Van Der HeydenMark WebsterMartin WinterhalterHüseyin InceRobert ZweikerAmin Ariff NuruddinThomas SchmitzMathias VrolixMadhav MenonBéla MerkelyRalph ToelgHelge MöllmannGillian A.j. JessurunIftikhar EbrahimHolger NefSebastian PhilippChristopher ZeitzDavid ErlingeFlorim CuculiStephan AchenbachGraham CasselChristoph LiebetrauEric EeckhoutJan TorzewskiManel SabatéWerner JungFranz R. EberliDougal MccleanEvald Høj ChristiansenJean FajadetStefan VerheyeGuy FriedrichRené J. Van Der SchaafHenning EbeltKristof GrafRafael Ruiz-salmerónMichael NguyenMarco MoccettiMarcus WiemerThomas BuckDirk WestermannVictor LegrandChristian M. ValinaLisette Okkels JensenHarald DariusAndrejs ĒRglisAdrian WlodarczakFabrizio TomaiNigel JepsonIrene LangAlexander SchmeisserCarlo TraniDidier CarriéJochen WöhrleJohan BennettAbid AssaliAngel CequierAdel AminianUlf LandmesserStephan KischeHans-heinrich MindenHuay Cheem TanMichael HaudeConstantin Von Zur MühlenMichael MagroPeter BarlisJohannes Brachmannsubject
Scaffoldmedicine.medical_specialtybusiness.industry0206 medical engineeringClinical performance02 engineering and technology030204 cardiovascular system & hematology020601 biomedical engineering03 medical and health sciences0302 clinical medicineInternal medicineCohortMedicineCardiology and Cardiovascular MedicinebusinessMonth follow updescription
The aim of this registry is to investigate the clinical performance and long-term safety of the Resorbable Magnesium Scaffold (Magmaris) (BIOTRONIK AG, Buelach, Switzerland) in a real-world setting. Up to 2,054 subjects in up to 120 clinical sites in Europe, Asia, and Asia-Pacific countries will
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-09-01 | Journal of the American College of Cardiology |